These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16862064)

  • 1. Therapeutic apheresis in the Republic of Macedonia - our five years experience (2000-2004).
    Milovanceva-Popovska M; Stojkovski Lj; Grcevska L; Dzikova S; Ristovska V; Gogovska L; Polenakovic M
    Prilozi; 2006 Jul; 27(1):37-44. PubMed ID: 16862064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in Casablanca.
    Tazi I; Merimi F; Majd A; Benchemsi N
    Transfus Apher Sci; 2008 Aug; 39(1):45-8. PubMed ID: 18583191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in elderly patients.
    Basic-Jukic N; Brunetta B; Kes P
    Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
    Haupt WF; Rosenow F; van der Ven C; Birkmann C
    Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of therapeutic hemapheresis in Norway year 2000.
    Taraldsrud E; Kvalheim G; Jørstad S; Stavem K; Aandahl GS
    Transfus Apher Sci; 2003 Apr; 28(2):135-41. PubMed ID: 12679117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.
    Momtaz M; Fayed A; Marzouk K; Shaker A
    Ther Apher Dial; 2018 Dec; 22(6):666-673. PubMed ID: 30009495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relevance of plasma exchange in the treatment of myasthenia gravis: study of 11 cases].
    Miladi MI; Feki I; Kammoun H; Elleuch H; Triki C; Gargouri J; Mhiri C
    Rev Med Interne; 2008 Feb; 29(2):87-93. PubMed ID: 18035453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in neurology patients-experience from single center in Montenegro.
    Roganovic M; Erakovic J; Radulovic L; Perunicic S; Milikic D; Vujovic B; Idrizovic Z; Vujovic S; Debeljevic M; Gluscevic S
    Ther Apher Dial; 2024 Feb; 28(1):125-130. PubMed ID: 37641163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of pediatric plasma apheresis in intensive care settings.
    Haque A; Sher G; Hoda M; Moiz B
    Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange.
    Kankirawatana S; Huang ST; Marques MB
    J Clin Apher; 2007; 22(5):265-9. PubMed ID: 17722047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with extracorporeal elimination therapy in myasthenia gravis.
    Blaha M; Pitha J; Blaha V; Lanska M; Maly J; Filip S; Brndiar M; Langrova H
    Transfus Apher Sci; 2011 Dec; 45(3):251-6. PubMed ID: 22018894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution.
    Rosenkvist J; Berkowicz A; Holsøe E; Sørensen H; Taaning E
    Vox Sang; 1984; 46(1):13-8. PubMed ID: 6702139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective.
    Agreda-Vásquez GP; Espinosa-Poblano I; Sánchez-Guerrero SA; Crespo-Solís E; Cabrera-Vásquez S; López-Salmorán J; Barajas J; Peñaloza-Ramírez P; Tirado-Cárdenas N; Velázquez A
    J Clin Apher; 2008; 23(5):163-7. PubMed ID: 18819155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W; Bucka C; Klingel R
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.